Vial Blinding Labels for Clinical Trials

Schreiner MediPharm’s vial blinding labels neutralize trial samples, masking color discrepancies between liquid active drugs and placebos while allowing for easy fill level determination.

Vial Blinding Labels For Clinical Trials

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Schreiner MediPharm’s self-adhesive film labels are colored with semi-transparent yellow coloration. They are designed for vials that are filled with a liquid active ingredient. Consequently, different liquids filled into vials can no longer be distinguished from each other. At the same time, however, the label is transparent enough for identifying the fill level of the liquid inside the vial.

Schreiner MediPharm designed the blinding label with WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO).

Fill out the form below to request more information about Vial Blinding Labels for Clinical Trials
Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026